vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and FTAI Infrastructure Inc. (FIP). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($263.6M vs $143.5M, roughly 1.8× FTAI Infrastructure Inc.). BALCHEM CORP runs the higher net margin — 14.9% vs -68.1%, a 83.0% gap on every dollar of revenue. On growth, FTAI Infrastructure Inc. posted the faster year-over-year revenue change (77.7% vs 9.8%). Over the past eight quarters, FTAI Infrastructure Inc.'s revenue compounded faster (31.9% CAGR vs 4.9%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
FTAI Infrastructure Inc. owns, operates and invests in high-quality critical infrastructure assets across core sectors including transportation logistics, midstream energy, and power generation. It primarily serves North American markets, focusing on assets with stable long-term cash flows, contracted revenue streams, and strong market positions to deliver sustainable returns for stakeholders.
BCPC vs FIP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $143.5M |
| Net Profit | $39.2M | $-97.7M |
| Gross Margin | 35.6% | — |
| Operating Margin | 19.8% | -45.7% |
| Net Margin | 14.9% | -68.1% |
| Revenue YoY | 9.8% | 77.7% |
| Net Profit YoY | 16.8% | 21.6% |
| EPS (diluted) | $1.21 | $-1.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $143.5M | ||
| Q3 25 | $267.6M | $140.6M | ||
| Q2 25 | $255.5M | $122.3M | ||
| Q1 25 | $250.5M | $96.2M | ||
| Q4 24 | $240.0M | $80.8M | ||
| Q3 24 | $239.9M | $83.3M | ||
| Q2 24 | $234.1M | $84.9M | ||
| Q1 24 | $239.7M | $82.5M |
| Q4 25 | $39.2M | $-97.7M | ||
| Q3 25 | $40.3M | $-104.5M | ||
| Q2 25 | $38.3M | $-70.0M | ||
| Q1 25 | $37.1M | $120.2M | ||
| Q4 24 | $33.6M | $-124.7M | ||
| Q3 24 | $33.8M | $-43.0M | ||
| Q2 24 | $32.1M | $-48.1M | ||
| Q1 24 | $29.0M | $-50.3M |
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — | ||
| Q1 24 | 34.0% | — |
| Q4 25 | 19.8% | -45.7% | ||
| Q3 25 | 20.4% | -70.8% | ||
| Q2 25 | 20.1% | -56.4% | ||
| Q1 25 | 20.4% | 81.8% | ||
| Q4 24 | 19.8% | -152.7% | ||
| Q3 24 | 20.0% | -51.7% | ||
| Q2 24 | 19.6% | -56.4% | ||
| Q1 24 | 17.4% | -58.8% |
| Q4 25 | 14.9% | -68.1% | ||
| Q3 25 | 15.1% | -74.4% | ||
| Q2 25 | 15.0% | -57.2% | ||
| Q1 25 | 14.8% | 125.0% | ||
| Q4 24 | 14.0% | -154.4% | ||
| Q3 24 | 14.1% | -51.6% | ||
| Q2 24 | 13.7% | -56.7% | ||
| Q1 24 | 12.1% | -60.9% |
| Q4 25 | $1.21 | $-1.04 | ||
| Q3 25 | $1.24 | $-1.38 | ||
| Q2 25 | $1.17 | $-0.73 | ||
| Q1 25 | $1.13 | $0.89 | ||
| Q4 24 | $1.03 | $-1.21 | ||
| Q3 24 | $1.03 | $-0.45 | ||
| Q2 24 | $0.98 | $-0.52 | ||
| Q1 24 | $0.89 | $-0.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $57.4M |
| Total DebtLower is stronger | — | $3.8B |
| Stockholders' EquityBook value | $1.3B | $21.3M |
| Total Assets | $1.7B | $5.7B |
| Debt / EquityLower = less leverage | — | 176.99× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $57.4M | ||
| Q3 25 | $65.1M | $34.7M | ||
| Q2 25 | $65.4M | $33.6M | ||
| Q1 25 | $49.9M | $26.3M | ||
| Q4 24 | $49.5M | $27.8M | ||
| Q3 24 | $73.7M | $20.3M | ||
| Q2 24 | $63.7M | $33.1M | ||
| Q1 24 | $60.3M | $23.0M |
| Q4 25 | — | $3.8B | ||
| Q3 25 | — | $3.7B | ||
| Q2 25 | — | $3.1B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.6B | ||
| Q1 24 | — | $1.3B |
| Q4 25 | $1.3B | $21.3M | ||
| Q3 25 | $1.3B | $181.1M | ||
| Q2 25 | $1.3B | $375.5M | ||
| Q1 25 | $1.2B | $476.2M | ||
| Q4 24 | $1.1B | $202.7M | ||
| Q3 24 | $1.2B | $370.8M | ||
| Q2 24 | $1.1B | $394.8M | ||
| Q1 24 | $1.1B | $402.5M |
| Q4 25 | $1.7B | $5.7B | ||
| Q3 25 | $1.7B | $5.5B | ||
| Q2 25 | $1.7B | $4.4B | ||
| Q1 25 | $1.6B | $4.1B | ||
| Q4 24 | $1.6B | $2.4B | ||
| Q3 24 | $1.6B | $2.4B | ||
| Q2 24 | $1.6B | $2.5B | ||
| Q1 24 | $1.6B | $2.3B |
| Q4 25 | — | 176.99× | ||
| Q3 25 | — | 20.59× | ||
| Q2 25 | — | 8.21× | ||
| Q1 25 | — | 5.79× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 4.14× | ||
| Q2 24 | — | 3.94× | ||
| Q1 24 | — | 3.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $-2.8M |
| Free Cash FlowOCF − Capex | — | $-68.6M |
| FCF MarginFCF / Revenue | — | -47.8% |
| Capex IntensityCapex / Revenue | — | 45.9% |
| Cash ConversionOCF / Net Profit | 1.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-398.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $-2.8M | ||
| Q3 25 | $65.6M | $-24.4M | ||
| Q2 25 | $47.3M | $-5.2M | ||
| Q1 25 | $36.5M | $-85.7M | ||
| Q4 24 | $52.3M | $-8.1M | ||
| Q3 24 | $51.3M | $14.2M | ||
| Q2 24 | $45.0M | $-17.6M | ||
| Q1 24 | $33.4M | $-3.9M |
| Q4 25 | — | $-68.6M | ||
| Q3 25 | — | $-90.7M | ||
| Q2 25 | — | $-87.5M | ||
| Q1 25 | — | $-151.7M | ||
| Q4 24 | — | $-34.3M | ||
| Q3 24 | — | $-11.7M | ||
| Q2 24 | — | $-32.1M | ||
| Q1 24 | — | $-16.7M |
| Q4 25 | — | -47.8% | ||
| Q3 25 | — | -64.5% | ||
| Q2 25 | — | -71.6% | ||
| Q1 25 | — | -157.7% | ||
| Q4 24 | — | -42.4% | ||
| Q3 24 | — | -14.0% | ||
| Q2 24 | — | -37.9% | ||
| Q1 24 | — | -20.3% |
| Q4 25 | — | 45.9% | ||
| Q3 25 | — | 47.2% | ||
| Q2 25 | — | 67.3% | ||
| Q1 25 | — | 68.6% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 31.1% | ||
| Q2 24 | — | 17.2% | ||
| Q1 24 | — | 15.6% |
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | -0.71× | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 1.15× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
FIP
| Power Revenues | $45.9M | 32% |
| Rail Revenue | $44.6M | 31% |
| Service Other | $22.8M | 16% |
| Gas Revenues | $15.3M | 11% |
| Roadside Services Revenues | $11.5M | 8% |
| Rapauno | $1.2M | 1% |
